Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma

Multiple myeloma (MM) drug resistance highlights a need for alternative therapeutic strategies. In this study, we show that CASIN, a selective inhibitor of cell division cycle 42 (Cdc42) GTPase, inhibited proliferation and survival of melphalan/bortezomib-resistant MM cells more profoundly than that...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Nguyen, Phuong, Chakrabarti, Jayati, Li, Yuan, Kalim, Khalid W., Zhang, Mengnan, Zhang, Lin, Zheng, Yi, Guo, Fukun
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779689/
https://ncbi.nlm.nih.gov/pubmed/31632904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00958
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky